SAN DIEGO, Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. ( NASDAQ:CAPR ) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.

Capricor治疗

<p>圣地亚哥，2025 年 10 月 3 日（GLOBE NEWSWIRE）-- Johnson Fistel, PLLP 正在调查代表 Capricor Therapeutics, Inc.（纳斯达克：CAPR）股东的潜在法律索赔，涉及某些高管和董事的涉嫌不当行为，这可能对公司及其投资者造成了损害</p>

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Capricor 治疗公司长期股东公告：Johnson Fistel 鼓励投资者联系以获取更多关于持续调查的信息